Forty-four recommendations, all accepted, and not one of them tells you what to do on Monday. That is the useful reading of the UK government's 6 October response to the National Commission into the Regulation of AI in Healthcare. If you are the person who has to decide which tools your practice approves, you now have a direction of travel from Whitehall and the same gaps you had a week ago: no new duty for private providers, and no settled answer on who is liable when an AI tool gets it wrong.
Three other stories this week test the claims that vendors make to people in your position. A hospital study found an AI drafting tool made clinicians slower at editing even though most of them felt faster. A large electronic record supplier found that patient records could be viewed without a trace in its logs. And a phone-assistant vendor raised $20 million on a user-growth figure nobody has checked.
1. The UK government accepts all 44 AI commission recommendations
On 6 October 2026 the government confirmed it will accept all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, which published its report on 10 September 2026. The commission is an independent, non-statutory body that the MHRA set up in September 2025, and it drew on a year-long evidence programme involving more than 12,000 patients, clinicians and members of the public. The central shift is from one-off approval of AI-enabled medical devices to monitoring them across their working life. The government also said it will explore staged authorisation, which would let promising tools into the NHS earlier under close supervision while real-world evidence builds up. Source: UK Government (gov.uk), 6 October 2026.
The dates matter more than the headline. The MHRA plans draft guidance on managing changes to AI-enabled devices as they adapt over time in December 2026, a consultation on how AI-enabled devices are classified in 2027, and a full implementation roadmap by spring 2027. AI Airlock, the MHRA's regulatory sandbox, has three more years of funding, with applications open now and the first innovators chosen in November 2026. A working group drawing on DHSC, MHRA, CQC and equivalent bodies is to strengthen reporting and learning from real-world use (Source: HTN, 6 October 2026). The response we read sets out no specific obligations for independent providers and does not mention liability by name; the nearest commitment is to improve redress when care falls below expectations.
That is the other half of last week's finding. Between 77% and 88% of 761 respondents told the commission that the legal framework for AI liability is insufficient or has significant gaps (Browne Jacobson, September 2026), and we covered it in last week's briefing. Accepting a recommendation is not the same as closing the gap, and the roadmap that would close it is six months away. Our earlier piece on what the HCPC and CSP say about AI is still the best summary of the professional rules you actually work under today.
So what for you: nothing new is binding yet, but lifecycle monitoring means a tool that was approved in March can change in September after a software update. Ask each supplier in writing whether the product is registered with the MHRA as a medical device, or why they say it is not, and diarise a re-check every six months. If you are CQC-registered, add AI tools to the governance log you already keep for incidents and complaints.
2. An AI discharge-summary tool made editing 32% slower
A study in Applied Clinical Informatics looked at 8,298 hospitalised adults whose discharge summaries were written before and after a GPT-4.1-based drafting tool was added to a hospital's templates. Overall edit time barely moved, from 6.60 to 6.28 minutes. But in the period after launch, notes where the AI was used took 32% longer to edit (95% confidence interval 24% to 41%): 9.20 minutes with the tool against 4.93 without. A faculty review of 27 encounters found the AI-assisted summaries scored higher on quality and lower on potential harm, but were less concise. And 31 of 36 surveyed clinicians (86.1%) said the tool had improved their efficiency. Source: Applied Clinical Informatics study (DOI 10.1055/a-2962-8004), as summarised by Yesil Science, 19 September 2026.
Treat the numbers with care. We read a secondary summary, not the full paper. The design was observational at a single hospital in medicine wards, so the notes that received an AI draft may simply have been the longer, more complicated ones. It says nothing directly about a four-clinician physiotherapy or dental practice. What it does show is a gap that every practice owner should recognise: people felt faster while the stopwatch said slower.
So what for you: do not accept time-saved claims, from vendors or from your own team's impressions. Frankly, a two-week test is cheap enough to run on every tool. Time ten notes written the old way and ten written with the tool, including the editing, and compare the medians. If the saving is under a minute a note, the subscription needs another reason to exist.
3. Epic finds patient records could be viewed without a log entry
Epic's chief security officer, Stirling Martin, told the New York Times on 30 September 2026 that the company had used Anthropic's Claude Mythos to test how attackers might use open-source AI agents to reach confidential records. The test found flaws in certain MyChart configurations that could let someone view patient records without the access showing up in audit logs. Epic said it was not clear whether records could be altered undetected. Founder and chief executive Judy Faulkner told Modern Healthcare the fixes would likely take about six weeks, with engineers moved off new product work. Epic points out that providers, not Epic, control the data. Source: PYMNTS, 8 October 2026, citing the New York Times and Modern Healthcare.
Epic is hospital software, and most independent practices will never touch it. The question transfers anyway. An audit log is the thing you rely on to prove who looked at a record, and the finding is that a log can be silent in exactly the case you most need it. Under UK GDPR your practice stays the data controller whatever your supplier's security claims say, and the regulation puts a 72-hour clock on reporting a notifiable breach to the ICO once you are aware of one (check the current ICO guidance before you rely on this).
So what for you: send every supplier that holds patient data one question this month. Does your system log every read of a patient record, can we see that log, and how would we know if it failed? Keep the reply. The evidence points toward treating a vendor who cannot answer in a week as a vendor to review at contract renewal.
4. Vocca raises $20 million on a growth claim you cannot check
Vocca, which sells an AI phone assistant for healthcare practices, announced a $20 million Series A. It says its user base grew from 2,000 to 15,000 practitioners in a year. Source: Vocca company blog, reported in HIStalk, 9 October 2026. That is the vendor describing its own customers, so treat it as a sales figure and not an independent measure of results. Growth in users says nothing about how many callers got what they needed.
It does confirm where the money is going: the front desk. Phone answering is the use case most likely to land in front of you this quarter, and the legal questions are less settled than the sales pitch suggests. We set out the layers in our Q&A on AI phone answering; it is written around US law, so UK practices should read the structure and check the ICO's guidance on recording calls and your own privacy notice for the local rules.
So what for you: if a vendor quotes you a user number, ask for three things in return, a reference practice of your size, the share of calls the tool resolves without a person, and what it does when it is unsure. Tell callers when an AI is answering. That costs one sentence in the greeting and removes the largest avoidable complaint.
What this week adds up to
The government has said where regulation is heading and when the detail will land. The studies and incidents this week say something more immediate: perception, vendor statistics and silent logs are all weak evidence, and each can be tested cheaply by a practice willing to measure for itself. A timing test, a logging question and a reference call will tell you more than any announcement.
If you are the person who has to make that case to a sceptical owner, a structured independent read saves weeks. The AI Opportunity and Growth Assessment benchmarks your practice against the CARE Framework and returns a ranked list of what to do first, so you are not choosing between 44 recommendations and a dozen sales calls. Or book a 20-minute discovery call and we will talk through which of this week's stories matters most for the tools you are weighing up.
The Clinical AI Briefing
One practical AI insight for healthcare practices every week. No hype. Evidence and outcomes only.